Neus Basté

Publicaciones destacadas

• Emerging systemic antitarget treatment for differentiated thyroid carcinoma

  Autores:

  Basté, N; Grau, JJ; Mora, M;

  Referencia: Current Opinion In Oncology 2021.

• Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

  Autores:

  Hitt, R; Iglesias, L; López-Pousa, A; Berrocal-Jaime, A; Grau, JJ;

  (...)

  León-Vintró, X; Cunquero-Tomas, AJ; Baste, N; Ocaña, A; Cruz-Hernández, JJ.

  Ver listado completo de autores

  Referencia: Clinical & Translational Oncology 2021.

• Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker

  Autores:

  Terra, X; Ceperuelo-Mallafré, V; Benaiges, E; Vendrell, J; Fernandez-Veledo, S;

  (...)

  Valduvieco, I; Basté, N; Camara, M; Gumà, J; Vilaseca, I.

  Ver listado completo de autores

  Referencia: Cancers 2021.

• Immunotherapy combinations for the treatment of patients with solid tumors

  Autores:

  Virginia Bluthgen, Maria; Bast, Neus; Recondo, Gonzalo;;

  Referencia: Future Oncology 2020.

• Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma

  Autores:

  Du, Chengrun; Blanchard, Pierre; Even, Caroline; Boros, Angela; Gorphe, Philippe;

  (...)

  Billard, Camelia; Janot, Francois; Mirghani, Haitham; Temam, Stephane; Tao, Yungan;.

  Ver listado completo de autores

  Referencia: Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck 2020.

• Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

  Autores:

  Burtness, Barbara; Harrington, Kevin J.; Greil, Richard; Soulieres, Denis; Tahara, Makoto;

  (...)

  Zhang, Yayan; Gumuscu, Burak; Cheng, Jonathan D.; Jin, Fan; Rischin, Danny;KEYNOTE-048 Investigators.

  Ver listado completo de autores

  Referencia: Lancet 2019.

• New approaches in salivary gland carcinoma

  Autores:

  Even C; Baste N; Classe M ;

  Referencia: Current Opinion In Oncology 2019.

• Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

  Autores:

  Saleh K; Daste A; Martin N; Pons-Tostivint E; Auperin A;

  (...)

  Bidault F; Guigay J; Le Tourneau C; Saada-Bouzid E; Even C .

  Ver listado completo de autores

  Referencia: European Journal Of Cancer 2019.

• SEOM clinical guidelines for the treatment of head and neck cancer (2017)

  Autores:

  Iglesias Docampo, L C; Arrazubi Arrula, V; Baste Rotllan, N; Carral Maseda, A; Cirauqui Cirauqui, B;

  Escobar, Y; Lambea Sorrosal, J J; Pastor Borgonon, M; Rueda, A; Cruz Hernandez, J J.

  Referencia: Clinical & Translational Oncology 2018.

• Comparison of Treatment Recommendations by Molecular Tumor Boards Worldwide

  Autores:

  Rieke, Damian T.; Lamping, Mario; Schuh, Marissa; Le Tourneau, Christophe; Baste, Neus;

  Burkard, Mark E.; Metzeler, Klaus H.; Leyvraz, Serge; Keilholz, Ulrich;.

  Referencia: Jco Precision Oncology 2018.